CNY 22.03
(-2.65%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | -30.65 Million | 13.31 Million | 22.35 Million | 104.83 Thousand | -132.98 Million | -2.7 Million |
Net Income | -32.95 Million | 70.32 Million | 162.84 Million | 57.63 Million | 26.18 Million | 22.89 Million |
Depreciation & Amortization | 59.89 Million | 54.65 Million | 976.62 Thousand | 899.84 Thousand | 1.06 Million | 1.08 Million |
Deferred income taxes | -12.72 Million | -8.56 Million | -1.31 Million | 2.82 Million | 2.23 Million | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -78.01 Million | -146.83 Million | -226.57 Million | -118.2 Million | -232.66 Million | -88.86 Million |
Other non-cash items | 7.77 Million | 35.17 Million | 85.11 Million | 59.77 Million | 72.42 Million | 62.17 Million |
Investing Cash Flow | -38.37 Million | -173.98 Million | -88.89 Million | -88.14 Million | -18.72 Million | -9.29 Million |
Investments in PPE | -139.68 Million | -73.95 Million | -89.66 Million | -87.94 Million | -19.15 Million | -9.64 Million |
Acquisitions | 788.99 Thousand | - | 903.04 Thousand | - | 327.44 Thousand | - |
Investment purchases | - | -100 Million | - | - | - | - |
Sales/Maturities of investments | 1.43 Million | - | - | - | - | - |
Other Investing Activities | 99.08 Million | -30.29 Thousand | -127.79 Thousand | -204.04 Thousand | 99.95 Thousand | 350.36 Thousand |
Financing Cash Flow | 26.9 Million | 365.08 Million | 74.2 Million | 136.94 Million | 151.52 Million | -3.75 Million |
Debt repayment | -90.68 Million | -866 Million | -279.3 Million | -139.52 Million | -80.32 Million | -249.82 Million |
Dividends payments | -18.59 Million | -25.56 Million | -29.62 Million | -22.37 Million | -16.37 Million | -17.07 Million |
Common Stock Repurchased | - | 20.97 Million | - | - | - | - |
Common Stock Issuance | -5 Million | -20.97 Million | - | - | - | - |
Other Financing Activities | -40.79 Million | 1.25 Billion | 383.13 Million | 298.83 Million | 248.22 Million | 263.13 Million |
Accounts receivables | -61.12 Million | -298.29 Million | -144.77 Million | -111.17 Million | -212.55 Million | -178.17 Million |
Accounts payables | 28.72 Million | 189.86 Million | -13.25 Million | -31.53 Million | -8.38 Million | - |
Inventory | -32.89 Million | -29.85 Million | -67.23 Million | 21.67 Million | -13.95 Million | -55.73 Million |
Other working capital | 16 Million | -8.56 Million | -1.31 Million | 2.82 Million | 2.23 Million | -33.13 Million |
Cash at beginning of period | 261.91 Million | 57.27 Million | 49.66 Million | 757.98 Thousand | 941.52 Thousand | 16.69 Million |
Cash at end of period | 219.46 Million | 261.91 Million | 57.27 Million | 49.66 Million | 757.98 Thousand | 941.52 Thousand |
Capital Expenditure | -139.68 Million | -73.95 Million | -89.66 Million | -87.94 Million | -19.15 Million | -9.64 Million |
Effect of forex changes on cash | -315.65 Thousand | 222.24 Thousand | -57.48 Thousand | 7394.73 | -118.88 | -0.02 |
Net cash flow / Change in cash | -42.44 Million | 204.63 Million | 7.61 Million | 48.9 Million | -183.54 Thousand | -15.75 Million |
Free Cash Flow | -170.33 Million | -60.64 Million | -67.31 Million | -87.83 Million | -152.13 Million | -12.34 Million |
Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -17.21 Million | 4.84 Million | -1.82 Million | -32.95 Million | -17.86 Million | -3.99 Million |
Depreciation & Amortization | - | 16.93 Million | 16.93 Million | 59.89 Million | 15.98 Million | -27.71 Million |
Deferred income taxes | - | - | - | -12.72 Million | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | -179.2 Million | - | -78.01 Million | -94.01 Million | 24.6 Million |
Other non-cash items | -124.8 Million | 28.74 Million | -44.22 Million | 7.77 Million | 80.68 Million | 9.04 Million |
Investing Cash Flow | -95.26 Million | -13.1 Million | -75.63 Million | -38.37 Million | 67.28 Million | -63.45 Million |
Investments in PPE | -75.26 Million | -13.1 Million | -39.73 Million | -139.68 Million | -34.92 Million | -63.45 Million |
Acquisitions | - | - | - | 788.99 Thousand | 788.99 Thousand | - |
Investment purchases | -20 Million | - | -35.9 Million | - | - | - |
Sales/Maturities of investments | - | - | - | 1.43 Million | 100 Million | - |
Other Investing Activities | - | - | -35.9 Million | 99.08 Million | 100 Million | - |
Financing Cash Flow | 408.42 Million | 33.19 Million | 66.11 Million | 26.9 Million | -385.87 Million | 315.82 Million |
Debt repayment | -291.62 Million | -46.82 Million | -98.78 Million | -90.68 Million | -361.37 Million | -384.4 Million |
Dividends payments | -2.41 Million | -974.3 Thousand | -2.17 Million | -18.59 Million | -18.59 Million | -20.77 Million |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | -5 Million | -5 Million | - |
Other Financing Activities | 119.21 Million | -13.38 Million | -30.49 Million | -40.79 Million | -23.75 Million | 721.01 Million |
Accounts receivables | - | -130.23 Million | - | -61.12 Million | -61.12 Million | 11.28 Million |
Accounts payables | - | - | - | 28.72 Million | - | - |
Inventory | - | -48.96 Million | - | -32.89 Million | -32.89 Million | 13.31 Million |
Other working capital | - | - | - | - | - | - |
Cash at beginning of period | 201.59 Million | 248.2 Million | 219.46 Million | 261.91 Million | 492.96 Million | 238.68 Million |
Cash at end of period | 372.59 Million | 283.84 Million | 164.64 Million | 219.46 Million | 219.46 Million | 492.96 Million |
Capital Expenditure | -75.26 Million | -13.1 Million | -39.73 Million | -139.68 Million | -34.92 Million | -63.45 Million |
Effect of forex changes on cash | -142.72 Thousand | 200.18 Thousand | 741.56 Thousand | -315.65 Thousand | -320.36 Thousand | -41.88 Thousand |
Net cash flow / Change in cash | 170.99 Million | 35.64 Million | -54.82 Million | -42.44 Million | -273.49 Million | 254.28 Million |
Free Cash Flow | -217.28 Million | 3.55 Million | -85.78 Million | -170.33 Million | 11.91 Million | -61.5 Million |
000039
4973
SUPREMEINF
336260
ACUT
ARS